MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China – November 5, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2012. Highlights for Third Quarter 2012 • Net revenues were $257.1 million, up 17.7% over the]

By | 2016-03-04T06:17:22+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change STYLE=”font-family:Times New

[Mindray Medical Announces Top Management Change STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president]

By | 2016-02-08T04:39:31+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Top Management Change STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million,]

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2012 Financial Results STYLE=”font-family:Times

[Mindray Announces Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million,]

By | 2016-02-08T04:37:40+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change SHENZHEN, China,November

[Mindray Medical Announces Top Management Change SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president and-CEO, has been appointed]

By | 2016-01-13T10:40:12+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million, up 17.7% over the]

By | 2016-01-13T10:39:26+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] CORRESP: (Original Filing)

[November 2, 2012 VIA EDGAR AND HAND DELIVERY Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Mindray Comment Letter 2011 Form 20-F Commission On behalf of Mindray]

MR [Mindray Medical International] CORRESP: November 2, 2012 VIA EDGAR AND HAND DELIVERY

[November 2, 2012 VIA EDGAR AND HAND DELIVERY Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Mindray Comment Letter 2011 Form 20-F Commission On behalf of Mindray]

MR [Mindray Medical International] CORRESP: (Original Filing)

[November2, 2012 VIA EDGAR AND HAND DELIVERY Mr.Martin James STYLE="font-family:Times New Roman" SIZE="2">Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 STYLE="font-family:Times New Roman" SIZE="2"> Filed April30, 2012 File No.001-33036 STYLE="font-family:Times New Roman" SIZE="2">Dear Mr.James:]

Skip to toolbar